Chargement en cours...
Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse
BACKGROUND: Endothelial dysfunction caused by increased oxidative stress is a critical initiator of macro- and micro-vascular disease development in diabetic patients. Ipragliflozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, offers a novel approach for the treatment of diabetes b...
Enregistré dans:
| Publié dans: | Front Cardiovasc Med |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5080286/ https://ncbi.nlm.nih.gov/pubmed/27833913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2016.00043 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|